EP 2349199 A2 20110803 - PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIODONTAL DISEASES
Title (en)
PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIODONTAL DISEASES
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR BEHANDLUNG VON PARODONTALEN ERKRANKUNGEN
Title (fr)
COMPOSITION PHARMACEUTIQUE POUR LE TRAITEMENT DES MALADIES PARODONTALES
Publication
Application
Priority
- PL 2009050024 W 20090828
- PL 38597208 A 20080828
Abstract (en)
[origin: WO2010024702A2] A pharmaceutical composition for the treatment of periodontitis. A pharmaceutical composition according to the present invention is in the form of a gel with a selected viscosity. Its active ingredient is a base comprising a cysteine protease inhibitor from egg protein, urine, human or animal amniotic fluid, human or animal placentae as well as plants, with an activity of 1 - 50 inhibition units, suspended in 50 g of a polyhydroxyl alcohol and 50 g of a 0.05 molar phosphate buffer solution at a p H of 6.0 to 7.5, from 20 to 50 % by mass, whereas its carrier comprises gelling substances, from 7 to 20 % by mass, as well as water to 100% by mass. The gelling substances may be methylcellulose, hydroxypropylmethyl-cellulose, carboxymethylcellulose sodium salt, gelatin, apple-citrus pectin or a dextran. Preferentially, additives in the form of polyhydroxyl alcohols and Nipagin are used.
IPC 8 full level
A61K 9/00 (2006.01)
CPC (source: EP)
A61K 9/0063 (2013.01); A61K 38/56 (2013.01); A61K 38/57 (2013.01); A61P 1/02 (2017.12)
Citation (search report)
See references of WO 2010024702A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
Designated extension state (EPC)
AL BA RS
DOCDB simple family (publication)
WO 2010024702 A2 20100304; WO 2010024702 A3 20110603; EP 2349199 A2 20110803; PL 219098 B1 20150331; PL 385972 A1 20100301
DOCDB simple family (application)
PL 2009050024 W 20090828; EP 09737192 A 20090828; PL 38597208 A 20080828